Your browser doesn't support javascript.
loading
A Cautionary tale for using read-across for cancer hazard classification: Case study of isoeugenol and methyl eugenol.
Zhang, Xiaoling; Felter, Susan P; Api, Anne Marie; Joshi, Kaushal; Selechnik, Dan.
Afiliação
  • Zhang X; Procter & Gamble, Central Product Safety, Mason, OH, USA. Electronic address: zhang.x.31@pg.com.
  • Felter SP; Procter & Gamble, Central Product Safety, Mason, OH, USA.
  • Api AM; Research Institute for Fragrance Materials, Inc., Woodcliff Lake, NJ, USA.
  • Joshi K; Research Institute for Fragrance Materials, Inc., Woodcliff Lake, NJ, USA.
  • Selechnik D; Research Institute for Fragrance Materials, Inc., Woodcliff Lake, NJ, USA.
Regul Toxicol Pharmacol ; 136: 105280, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36367523
ABSTRACT
Chemical grouping and read-across are frequently used non-animal alternatives for filling toxicological data gaps. When grouping chemicals, it is critical to define the applicability domain because minor differences in chemical structure can lead to significant differences in toxicity. Here, we present a case study on isoeugenol and methyl eugenol, which are scheduled for review by IARC in June 2023, to illustrate that structural similarity alone may not be sufficient to group chemicals for hazard classification. Isoeugenol and methyl eugenol are plant-derived phenylpropenes that share similar physicochemical properties. The major metabolic pathway for isoeugenol includes conjugation of the phenolic hydroxyl group with sulfate and glucuronic acid as an efficient detoxification process, whereas the major metabolic pathway for methyl eugenol involves benzylic hydroxylation and formation of the 1'-sulfoxymethyleugenol which leads to carbocation formation. The carbocation can form DNA adducts and induce genotoxicity and carcinogenicity. Consistently, genotoxicity and carcinogenicity alerts are identified from in silico prediction tools for methyl eugenol but not isoeugenol. Moreover, the available toxicogenomic, genotoxicity, and carcinogenicity studies confirm that these chemicals have significantly different bioactivities. Data on other structurally similar chemicals further supports our conclusion that it is not appropriate to group these two chemicals for cancer hazard classification.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eugenol / Neoplasias Limite: Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eugenol / Neoplasias Limite: Humans Idioma: En Revista: Regul Toxicol Pharmacol Ano de publicação: 2022 Tipo de documento: Article